This randomized phase III trial studies how well Lactobacillus plantarum works in preventing
acute graft versus host disease in children undergoing donor stem cell transplant.
Lactobacillus plantarum may help prevent the development of gastrointestinal graft versus
host disease in children, adolescents, and young adults undergoing donor stem cell
transplant.
Intervention
Allogeneic Hematopoietic Stem Cell Transplantation, Lactobacillus plantarum strain 299, Lactobacillus plantarum strain 299v, Placebo Administration
Condition
Hematopoietic and Lymphoid System Neoplasm, Leukemia, Lymphoma, Plasma Cell Myeloma
Investigators
Michael L Nieder